use of next generation sequencing and synergy susceptibility testing in diagnosis and treatment of carbapenem-resistant klebsiella pneumoniae blood stream infection
Clicks: 177
ID: 169542
2018
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Emerging Content
30.0
/100
177 views
27 readers
AI Quality Assessment
Not analyzed
Readership in this journal
EmergingRanked #29 of 73 articles by views in international journal for parasitology
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Early diagnosis and appropriate treatment for carbapenem-resistant Klebsiella pneumoniae (CR-Kp) infection is a big challenge for clinicians due to its high mortality. Every effort has been made to improve its clinical outcomes. However, treatment according to synergy susceptibility testing has never been reported in the literature. We reported a 29-year-old systemic lupus erythematosus female with CR-Kp blood stream infection. We highlighted the identification by next generation sequencing and treatment according to synergy susceptibility testing in the case.
| Reference Key |
yu2018caseuse
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | ;Yuetian Yu;Fupin Hu;Cheng Zhu;Erzhen Chen;Liangjing Lu;Yuan Gao |
| Journal | international journal for parasitology |
| Year | 2018 |
| DOI |
10.1155/2018/3295605
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.